Hanze Hu
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoparticle-Based Drug Delivery 6
-
- Nanoplatforms for cancer theranostics 16
Hanze Hu
32 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Biomaterials 795
- Biomedical Engineering 1.3k
- Molecular Medicine 109
- Immunology 426
- Pharmaceutical Science 116
Countries citing papers authored by Hanze Hu
This map shows the geographic impact of Hanze Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanze Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanze Hu more than expected).
Fields of papers citing papers by Hanze Hu
This network shows the impact of papers produced by Hanze Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanze Hu. The network helps show where Hanze Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hanze Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 67 | |
| 3 | A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease Hit paper breakdown → | 2022 | 175 |
| 4 | 2022 | 76 | |
| 5 | Design of therapeutic biomaterials to control inflammation Hit paper breakdown → | 2022 | 361 |
| 6 | 2022 | 14 | |
| 7 | 2022 | 70 | |
| 8 | 2022 | 19 | |
| 9 | 2021 | 78 | |
| 10 | 2021 | 76 | |
| 11 | 2020 | 143 | |
| 12 | 2020 | 68 | |
| 13 | 2020 | 201 | |
| 14 | 2020 | 46 | |
| 15 | 2020 | 96 | |
| 16 | 2019 | 207 | |
| 17 | 2019 | 78 | |
| 18 | 2018 | 325 | |
| 19 | 2018 | 56 | |
| 20 | 2018 | 62 |
About Hanze Hu
Hanze Hu is a scholar working on Biomaterials, Biomedical Engineering, Molecular Medicine, Surfaces, Coatings and Films and Physiology, having authored 32 papers that have together received 2.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (16 papers), Extracellular vesicles in disease (8 papers), Nanoparticle-Based Drug Delivery (6 papers), RNA Interference and Gene Delivery (4 papers), Advanced Nanomaterials in Catalysis (3 papers), Virus-based gene therapy research (2 papers), Neonatal Respiratory Health Research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Biomaterials (795 citations), Biomedical Engineering (1.3k citations), Molecular Medicine (109 citations), Immunology (426 citations) and Pharmaceutical Science (116 citations). Hanze Hu has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Dan Shao, Mingqiang Li, Kam W. Leong, Yeh‐Hsing Lao, Huize Yan, Zhaoxu Tu, Zhimin Chang, Xiao Zheng, Chao Yang and Li Chen. Their work appears in journals such as Advanced Science, Advanced Materials, Journal of Materials Chemistry B, Science Advances and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.